These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 17945286

  • 1. mRNA expression profiles of methylated APAF-1 and DAPK-1 tumor suppressor genes uncover clear cell renal cell carcinomas with aggressive phenotype.
    Christoph F, Hinz S, Kempkensteffen C, Schostak M, Schrader M, Miller K.
    J Urol; 2007 Dec; 178(6):2655-9. PubMed ID: 17945286
    [Abstract] [Full Text] [Related]

  • 2. Promoter hypermethylation profile of kidney cancer with new proapoptotic p53 target genes and clinical implications.
    Christoph F, Weikert S, Kempkensteffen C, Krause H, Schostak M, Köllermann J, Miller K, Schrader M.
    Clin Cancer Res; 2006 Sep 01; 12(17):5040-6. PubMed ID: 16951219
    [Abstract] [Full Text] [Related]

  • 3. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.
    Kong WJ, Zhang S, Guo C, Zhang S, Wang Y, Zhang D.
    Laryngoscope; 2005 Aug 01; 115(8):1395-401. PubMed ID: 16094112
    [Abstract] [Full Text] [Related]

  • 4. Comparative promoter methylation analysis of p53 target genes in urogenital cancers.
    Christoph F, Hinz S, Weikert S, Kempkensteffen C, Schostak M, Miller K, Schrader M.
    Urol Int; 2008 Aug 01; 80(4):398-404. PubMed ID: 18587251
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Expression of death-associated protein kinase during tumour progression of human renal cell carcinomas: hypermethylation-independent mechanisms of inactivation.
    Wethkamp N, Ramp U, Geddert H, Schulz WA, Florl AR, Suschek CV, Hassan M, Gabbert HE, Mahotka C.
    Eur J Cancer; 2006 Jan 01; 42(2):264-74. PubMed ID: 16386893
    [Abstract] [Full Text] [Related]

  • 10. Positive correlation of tissue inhibitor of metalloproteinase-3 and death-associated protein kinase hypermethylation in head and neck squamous cell carcinoma.
    Nayak CS, Carvalho AL, Jeronimo C, Henrique R, Kim MM, Hoque MO, Chang S, Jiang WW, Koch W, Westra W, Sidransky D, Califano J.
    Laryngoscope; 2007 Aug 01; 117(8):1376-80. PubMed ID: 17592394
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Methylation of the APAF-1 and DAPK-1 promoter region correlates with progression of renal cell carcinoma in North Indian population.
    Ahmad ST, Arjumand W, Seth A, Saini AK, Sultana S.
    Tumour Biol; 2012 Apr 01; 33(2):395-402. PubMed ID: 21922274
    [Abstract] [Full Text] [Related]

  • 13. Promoter hypermethylation of death-associated protein kinase gene in cholangiocarcinoma.
    Liu XF, Kong FM, Xu Z, Yu SP, Sun FB, Zhang CS, Huang QX, Zhou XT, Song ZW.
    Hepatobiliary Pancreat Dis Int; 2007 Aug 01; 6(4):407-11. PubMed ID: 17690039
    [Abstract] [Full Text] [Related]

  • 14. Promoter methylation of p16INK4a, RASSF1A, and DAPK is frequent in salivary adenoid cystic carcinoma.
    Li J, El-Naggar A, Mao L.
    Cancer; 2005 Aug 15; 104(4):771-6. PubMed ID: 15959912
    [Abstract] [Full Text] [Related]

  • 15. Promoter methylation of death-associated protein kinase and its role in irradiation response in cervical cancer.
    Leung RC, Liu SS, Chan KY, Tam KF, Chan KL, Wong LC, Ngan HY.
    Oncol Rep; 2008 May 15; 19(5):1339-45. PubMed ID: 18425396
    [Abstract] [Full Text] [Related]

  • 16. Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA.
    Urakami S, Shiina H, Enokida H, Hirata H, Kawamoto K, Kawakami T, Kikuno N, Tanaka Y, Majid S, Nakagawa M, Igawa M, Dahiya R.
    Clin Cancer Res; 2006 Dec 01; 12(23):6989-97. PubMed ID: 17145819
    [Abstract] [Full Text] [Related]

  • 17. Death-associated protein kinase (DAPK) promoter methylation and response to neoadjuvant radiochemotherapy in esophageal cancer.
    Brabender J, Arbab D, Huan X, Vallböhmer D, Grimminger P, Ling F, Neiss S, Bollschweiler E, Schneider PM, Hölscher AH, Metzger R.
    Ann Surg Oncol; 2009 May 01; 16(5):1378-83. PubMed ID: 19224282
    [Abstract] [Full Text] [Related]

  • 18. Decreased expression of the human stem cell marker, Rex-1 (zfp-42), in renal cell carcinoma.
    Raman JD, Mongan NP, Liu L, Tickoo SK, Nanus DM, Scherr DS, Gudas LJ.
    Carcinogenesis; 2006 Mar 01; 27(3):499-507. PubMed ID: 16344273
    [Abstract] [Full Text] [Related]

  • 19. Down-regulation of LATS1 and LATS2 mRNA expression by promoter hypermethylation and its association with biologically aggressive phenotype in human breast cancers.
    Takahashi Y, Miyoshi Y, Takahata C, Irahara N, Taguchi T, Tamaki Y, Noguchi S.
    Clin Cancer Res; 2005 Feb 15; 11(4):1380-5. PubMed ID: 15746036
    [Abstract] [Full Text] [Related]

  • 20. Methylation of BNIP3 and DAPK indicates lower response to chemotherapy and poor prognosis in gastric cancer.
    Sugita H, Iida S, Inokuchi M, Kato K, Ishiguro M, Ishikawa T, Takagi Y, Enjoji M, Yamada H, Uetake H, Kojima K, Sugihara K.
    Oncol Rep; 2011 Feb 15; 25(2):513-8. PubMed ID: 21152877
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.